Chemoinformaics analysis of Quercetin-7-o-rutinoside
| Molecular Weight | 610.521 | nRot | 6 |
| Heavy Atom Molecular Weight | 580.281 | nRig | 30 |
| Exact Molecular Weight | 610.153 | nRing | 5 |
| Solubility: LogS | -3.19 | nHRing | 3 |
| Solubility: LogP | 0.043 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 77.9258 |
| nHD | 10 | BPOL | 39.6442 |
| QED | 0.14 |
| Synth | 4.79 |
| Natural Product Likeliness | 1.963 |
| NR-PPAR-gamma | 0.604 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.998 |
| HIA | 0.885 |
| CACO-2 | -6.546 |
| MDCK | 0.0000213 |
| BBB | 0.036 |
| PPB | 0.897355 |
| VDSS | 0.711 |
| FU | 0.122419 |
| CYP1A2-inh | 0.125 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.075 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.003 |
| CL | 1.382 |
| T12 | 0.703 |
| hERG | 0.246 |
| Ames | 0.859 |
| ROA | 0.032 |
| SkinSen | 0.922 |
| Carcinogencity | 0.126 |
| EI | 0.513 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.87 |
| Antiviral | Yes |
| Prediction | 0.748811 |